Infiltrating CD4/CD8 high T cells shows good prognostic impact in pancreatic cancer

被引:0
作者
Wang, Zhenxia [1 ]
Zhao, Jianguo [1 ]
Zhao, Haiping [1 ]
Sileng, A. [1 ]
Liu, Zhonghua [1 ]
Zhang, Yanfei [1 ]
Liu, Xitao [1 ]
Wang, Fei [1 ]
机构
[1] Inner Mongolia Med Coll Affiliated Hosp, Dept Gen Surg, 1 Tongdao North St, Hohhot 010050, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2017年 / 10卷 / 08期
基金
中国国家自然科学基金;
关键词
Pancreatic cancer; tumor infiltrating lymphocytes; marker; IMMUNE CELLS; CD4(+); MICROENVIRONMENT; IMPROVE; ROLES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor infiltrating lymphocytes in a certain tumor microenvironment are associated with the prognosis of cancer patients. The function of CD4(+) and CD8(+) T cells in the microenvironment of pancreatic cancer remains largely unknown. This study aimed to investigate the prognostic value of both CD4(+) and CD8(+) TIL subsets and their combined role in pancreatic cancer. In this study, pancreatic cancer tissues and corresponding adjacent normal tissues were collected from 90 patients. The expression levels of CD4 and CD8(+) T cells in pancreatic cancer tissues were detected by immunohistochemistry method. The results showed that CD4(+) iTIL expression was significantly correlated with tumor stage. CD8(+) iTILs were significantly correlated with lymphatic vessel invasion and tumor stage; CD8(+) sTILs not only showed correlation with lymphatic vessel invasion and tumor stage, but also had correlation with pathologic differentiation; the survival time of high CD4 expression group was longer compared to the low CD4 expression group. CD4(+) T cells were capable of killing tumor cells and prolonging the survival time of patients either directly or indirectly. According to Cox regression analysis, it was indicated that pathological differentiation, lymphatic vessel invasion, tumor stage, CD4(+) and CD8(+) TILs were the principle risk factors of pancreatic cancer prognosis. Especially multivariate analysis showed that pathological differentiation and the combination of CD4(+) and CD8(+) TILs expression were independent predictors of pancreatic cancer survival. Expression levels of CD4(+) and CD8(+) TILs in pancreatic cancer may provide promising and useful markers for prognosis of pancreatic cancer.
引用
收藏
页码:8820 / 8828
页数:9
相关论文
共 50 条
  • [21] IDENTIFICATION OF BICLONAL (DUPLEX) LEUKEMIC-CELLS EXPRESSING EITHER CD4(+)/CD8(-) OR CD4(-)/CD8(+) FROM A PATIENT WITH ADULT T-CELL LEUKEMIA-LYMPHOMA
    KONDO, S
    KOTANI, T
    TSUMORI, S
    NARAHARA, S
    ARATAKE, Y
    KOBAYASHI, M
    TAKAHASHI, M
    INOUE, S
    OHTAKI, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (03) : 669 - 671
  • [22] Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells - Implications for systemic control
    Wang, H.
    Mendez, L.
    Morton, G.
    Loblaw, A.
    Chung, H. T.
    Cheung, P.
    Mesci, A.
    Escueta, V.
    Petchiny, T. N.
    Huang, X.
    White, S. D.
    Downes, M.
    Vesprini, D.
    Liu, S. K.
    RADIOTHERAPY AND ONCOLOGY, 2024, 191
  • [23] CD8 lethargy in the absence of CD4 help
    Bourgeois, C
    Veiga-Fernandes, H
    Joret, AM
    Rocha, B
    Tanchot, C
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (08) : 2199 - 2207
  • [24] Depletion of CD4 and CD8 Positive T Cells Impairs Venous Thrombus Resolution in Mice
    Mukhopadhyay, Subhradip
    Gabre, Joel
    Chabasse, Christine
    Bromberg, Jonathan S.
    Antalis, Toni M.
    Sarkar, Rajabrata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (05)
  • [25] Co-cultivation of CD4+ and CD8+ human T-cells leads to the appearance of CD4 cells expressing CD8 through de novo synthesis of the CD8 α-subunit
    O'Donovan, MR
    Jones, DRE
    Robins, RA
    Li, KF
    Shim, HK
    Zheng, ZH
    Arlett, CF
    Capulas, E
    Cole, J
    HUMAN IMMUNOLOGY, 1999, 60 (11) : 1018 - 1027
  • [26] Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
    Teramatsu, Katsuhito
    Oono, Takamasa
    Oyama, Koki
    Fujimori, Nao
    Murakami, Masatoshi
    Yasumori, Sho
    Ohno, Akihisa
    Matsumoto, Kazuhide
    Takeno, Ayumu
    Nakata, Kohei
    Nakamura, Masafumi
    Ogawa, Yoshihiro
    BMC CANCER, 2022, 22 (01)
  • [27] CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy
    Hald, Sigurd M.
    Bremnes, Roy M.
    Al-Shibli, Khalid
    Al-Saad, Samer
    Andersen, Sigve
    Stenvold, Helge
    Busund, Lill-Tove
    Donnem, Tom
    LUNG CANCER, 2013, 80 (02) : 209 - 215
  • [28] MURINE LUPUS IN MRL/LPR MICE LACKING CD4 OR CD8 T-CELLS
    KOH, DR
    HO, A
    RAHEMTULLA, A
    FUNGLEUNG, WP
    GRIESSER, H
    MAK, TW
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) : 2558 - 2562
  • [29] The transcriptomics profiling of blood CD4 and CD8 T-cells in narcolepsy type I
    Khajavi, Leila
    Nguyen, Xuan-Hung
    Queriault, Clemence
    Chabod, Marianne
    Barateau, Lucie
    Dauvilliers, Yves
    Zytnicki, Matthias
    Liblau, Roland
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] CD4 AND CD8 EXPRESSION BY HUMAN AND MOUSE THYMIC DENDRITIC CELLS
    WINKEL, K
    SOTZIK, F
    VREMEC, D
    CAMERON, PU
    SHORTMAN, K
    IMMUNOLOGY LETTERS, 1994, 40 (02) : 93 - 99